Hong, J. H., Lee, K. S., Sim, S. H., Jung, K. H., Ahn, H. K., Shin, J., Ahn, J. S., Lee, S., Kang, S., Lee, S. Y., Kim, H. T. (2026). Phase 1b dose-expansion study of IMC-002, a anti-CD47 monoclonal antibody, in patients with advanced triple negative breast cancer (TNBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2524